Stock Price
13.90
Daily Change
0.36%
Yearly
-21.60%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
LG Chem 773,000.00 39,000.00 5.31% -22.62%
Fujifilm 8,352.00 -105.00 -1.24% 36.20%
AbbVie 135.87 2.35 1.76% 22.94%
Acadia Pharmaceuticals 23.05 0.91 4.11% -57.04%
Aerie Pharmaceuticals 7.55 0.09 1.21% -45.88%
Akebia Therapeutics 2.20 0.07 3.29% -27.87%
ALKERMES 25.25 0.38 1.53% 12.87%
Alnylam Pharmaceuticals 148.50 0.50 0.34% -10.74%
Alexion Pharmaceuticals 182.50 0 0% 70.54%
Amgen 235.36 4.51 1.95% -4.13%
Amarin 3.52 0.05 1.44% -42.01%
Baxter International 85.74 -0.15 -0.17% 7.12%
Biogen 239.30 2.63 1.11% -13.25%
Bluebird Bio 8.73 0.21 2.46% -82.72%
BioMarin Pharmaceutical 90.22 2.06 2.34% 8.74%
Bristol-Myers Squibb 64.93 0.33 0.51% -2.42%
Coherus Biosciences 13.90 0.05 0.36% -21.60%
Endo International Ordinary Shares 3.27 -0.06 -1.80% -54.07%
Gilead Sciences 71.77 -0.11 -0.15% 13.33%
Horizon Pharma 91.10 0.70 0.77% 15.73%
Ironwood Pharmaceuticals 11.72 0.36 3.17% 6.26%
Jazz Pharmaceuticals 144.50 0.91 0.63% -13.84%
Eli Lilly 244.12 -5.55 -2.22% 27.97%
Merck & Co 81.38 0.06 0.07% -2.40%
Myriad Genetics 27.79 1.31 4.95% 4.04%
Pacira 64.08 2.75 4.48% -13.03%
Pfizer 54.95 -0.59 -1.06% 49.73%
Perrigo 39.73 0.11 0.28% -9.11%
PTC Therapeutics 43.75 1.52 3.60% -36.12%
Regeneron Pharmaceuticals 615.24 -0.87 -0.14% 18.79%
Revance Therapeutics 15.36 0.31 2.06% -46.37%
Sarepta Therapeutics 71.10 -1.29 -1.78% -21.28%
Teva Pharmaceutical Industries Ltd 2,873.00 24.00 0.84% -21.40%
Vertex Pharmaceuticals 234.06 7.48 3.30% 3.77%
Xencor 37.05 0.94 2.60% -23.55%
Zoetis 206.18 -0.82 -0.40% 27.62%

Indexes Price Day Year
NASDAQ 14894 86.94 0.59% 14.58%
US400 2783 -9.12 -0.33% 14.79%

Coherus Biosciences
Coherus BioSciences, Inc. is a commercial stage biotherapeutics company. The Company is focused on the biosimilar and immuno-oncology market primarily in the United States. The Company’s pipeline includes the four categories product candidates, Oncology pipeline, Immunology pipeline, Ophthalmology pipeline and Small Molecule pipeline. Oncology pipeline includes Toripalimab, an anti-PD-1 antibody; UDENYCA (pegfilgrastim-cbqv); CHS-305, a bevacizumab (Avastin) biosimilar. Immunology pipeline includes CHS-1420, an anti-TNF product candidate, as an adalimumab (Humira) biosimilar. Ophthalmology pipeline includes CHS-201, a ranibizumab (Lucentis) biosimilar. CHS-201, a ranibizumab (Lucentis) biosimilar. Small Molecule pipeline includes CHS-131, an oral, small-molecule drug candidate. CHS-131 is a once-daily oral drug candidate for non-alcoholic steatohepatitis (NASH) and other metabolic conditions.